Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression

Published:2019-01 Issue:1 Volume:21 Page:96-106
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Deng Mingyang,Yuan Huan,Liu Sufang,Hu Zhiping,Xiao Han

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference37 articles.

1. Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials;Gengenbach;Leuk Lymphoma,2018

2. Living With Multiple Myeloma: A Focus Group Study of Unmet Needs and Preferences for Survivorship Care;Monterosso;J Patient Exp,2018

3. Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway;Tremblay-LeMay;J Hematol Oncol,2018

4. Short overview on the current standard of treatment in newly diagnosed multiple myeloma;Willenbacher;Memo,2018

5. Multiple myeloma - a cure within reach;Gertz;Leuk Lymphoma,2018

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets;Pathology - Research and Practice;2024-08

2. Highlighting the role of long non-coding RNA (LncRNA) in multiple myeloma (MM) pathogenesis and response to therapy;Medical Oncology;2024-06-07

3. A Comprehensive Review on Circulating cfRNA in Plasma: Implications for Disease Diagnosis and Beyond;Diagnostics;2024-05-17

4. Understanding exosomes: Part 2—Emerging leaders in regenerative medicine;Periodontology 2000;2024-02

5. The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy;Frontiers in Oncology;2024-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3